Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market. The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement. The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).

Reddy博士的实验室周五表示，他们已经在美国市场推出了一种仿制药，用于治疗多种细菌感染。总部位于海得拉巴的制药商在一份声明中表示，该公司已在美国市场推出强力霉素胶囊（40毫克）。该公司的产品是经美国食品和药物管理局（USFDA）批准的相当于Oracea胶囊（40毫克）的治疗性仿制药。

Shares of the company on Friday ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.(You can now subscribe to our Economic Times WhatsApp channel)(You can now subscribe to our Economic Times WhatsApp channel).

该公司股票周五在BSE收于每股6332.85卢比，涨幅0.71%。（您现在可以订阅我们的经济时报WhatsApp频道）（您现在可以订阅我们的经济时报WhatsApp频道）。